ScholarIQanswers from OpenAlex

Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography

PaperCitations, authors & open-access status

Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography have?

ScholarIQcitation count

Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography has 76 citations in the OpenAlex counts ScholarIQ stores.

When was Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography published?

ScholarIQyear

Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography has 2019 year in the ScholarIQ index.

What is the open-access status of Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography?

ScholarIQoa status

Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography has gold oa status in the ScholarIQ index.

What is the DOI of Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography?

ScholarIQdoi

The DOI for Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography is on the source record.

What is the PMID of Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography?

ScholarIQpmid

The PMID for Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography is on the source record.

What is the OpenAlex record for Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography?

ScholarIQopenalex

The OpenAlex for Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial